Cargando…
Angiotensinogen Suppression: A New Tool to Treat Cardiovascular and Renal Disease
Multiple types of renin-angiotensin system (RAS) blockers exist, allowing interference with the system at the level of renin, angiotensin-converting enzyme, or the angiotensin II receptor. Yet, in particular, for the treatment of hypertension, the number of patients with uncontrolled hypertension co...
Autores principales: | Cruz-López, Edwyn O., Ye, Dien, Wu, Congqing, Lu, Hong S., Uijl, Estrellita, Mirabito Colafella, Katrina M., Danser, A.H. Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444253/ https://www.ncbi.nlm.nih.gov/pubmed/35904033 http://dx.doi.org/10.1161/HYPERTENSIONAHA.122.18731 |
Ejemplares similares
-
Conventional Vasopressor and Vasopressor‐Sparing Strategies to Counteract the Blood Pressure–Lowering Effect of Small Interfering RNA Targeting Angiotensinogen
por: Uijl, Estrellita, et al.
Publicado: (2022) -
Targeting Angiotensinogen With N-Acetylgalactosamine–Conjugated Small Interfering RNA to Reduce Blood Pressure
por: Ye, Dien, et al.
Publicado: (2023) -
Blood pressure‐independent renoprotective effects of small interference RNA targeting liver angiotensinogen in experimental diabetes
por: Cruz‐López, Edwyn O., et al.
Publicado: (2022) -
Antisense oligonucleotides targeting hepatic angiotensinogen reduce atherosclerosis and liver steatosis in hypercholesterolemic mice
por: Ye, Dien, et al.
Publicado: (2023) -
From ARB to ARNI in Cardiovascular Control
por: Uijl, Estrellita, et al.
Publicado: (2016)